Ticaboom 90 Tablet
Marketer
Inuen Healthcare Pvt Ltd
Salt Composition
Ticagrelor (90mg)
Overview Ticaboom 90 Tablet
CardioGuard 90mg tablets are antiplatelet agents, also known as blood thinners. They inhibit the development of dangerous blood clots within blood vessels, thus lowering the risk of stroke or heart attack in patients with cardiovascular disease. CardioGuard 90mg is also indicated for individuals recovering from a recent heart attack, experiencing severe angina (unstable chest pain), or post-stent placement. It helps prevent further cardiac events, including repeat heart attacks, strokes, and clot formation within stents. Concurrent use with aspirin, another antiplatelet drug, is typical. CardioGuard 90mg can be ingested with or without food, consistently at the same time daily. Continuous use is crucial, even during periods of well-being; discontinuation raises the risk of recurrent cardiac events. The most frequent adverse effect is bleeding, potentially prolonged in cases of injury. While typically mild and self-limiting, persistent bleeding or worsening should be reported. Some individuals experience mild shortness of breath, usually resolving spontaneously. CardioGuard 90mg is contraindicated in patients with active internal bleeding (e.g., stomach ulcers, intracranial hemorrhage) or liver disease. Pre-existing conditions should be disclosed to your physician before initiating treatment.
Primary Ingredients of Ticaboom 90 Tablet
No text provided to rephrase.
Uses of Ticaboom 90 Tablet
Averting cardiovascular events such as myocardial infarction and cerebrovascular accident
Major Benefits of Ticaboom 90 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Ingest the Ticaboom 90 Tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, though consistent timing is recommended.
Common Side effects of Ticaboom 90 Tablet:
- Bleeding
- Breathlessness
How to use Ticaboom 90 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Ticaboom 90 Tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, though consistent timing is recommended for optimal results.
How Ticaboom 90 Tablet works:
Platelet aggregation is inhibited by Ticaboom 90 Tablet, an antithrombotic agent. This action reduces the risk of dangerous clot formation, consequently lowering the likelihood of stroke or myocardial infarction.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Ticaboom 90 Tablet concurrently with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
The use of Ticaboom 90 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Ticaboom 90 Tablet use while breastfeeding is absent. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Ticaboom 90 Tablet.
KidneySAFE IF PRESCRIBED
Ticaboom 90 Tablets pose no safety concerns for individuals with kidney impairment; dosage modification is unnecessary. Data regarding Ticaboom 90 Tablet use in patients undergoing renal dialysis are currently limited.
LiverCAUTION
Patients with liver impairment should exercise caution when using Ticaboom 90 Tablets, as dose modification may be necessary. Consult a physician before use. Ticaboom 90 Tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Ticaboom 90 Tablet :
Should you forget a Ticaboom 90 Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ticaboom 90 Tablet
| Label | Value |
|---|---|
| Chemical Type | Triazolo[1,5-a]pyrimidines |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | ADP receptor antagonists (P2Y12 inhibitors) |



